Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1427-1433

  Hebbar, Mohamed ^a   Révillion, Françoise ^a   Louchez, Marie Michèle ^a   Fournier, Charles ^a   Bonneterre, Jacques ^a   Peyrat, Jean Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0344417143     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. McGuire, W. L., and Clark, G. M. Prognostic factors and treatment decisions in axillary node-negative breast cancer. N. Engl. J. Med., 326: 1756-1761, 1992.
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet, 339: 1-15, 1992.
3. Gasparini, G., Pozza, F., and Harris, A. L. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J. Natl. Cancer Inst. (Bethesda), 85: 1206-1219, 1993.
4. Folkman, J. Angiogenesis and breast cancer. J. Clin. Oncol., 12: 441-443, 1994.
5. Bevilacqua, M. P., Pober, J. S., Mendrick, D. L., Cotran, R. S., and Gimbrone, M. A., Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA, 84: 9238-9242, 1987.
6. Leeuwenberg, J. F. M., Jeunhomme, T. M. A. A., and Buurman, W. A. Role of ELAM-1 in adhesion of monocytes to activated human endothelial cells. Scand. J. Immunol., 35: 335-341, 1992.
7. Zetter, B. R. Adhesion molecules in tumor metastasis. Semin. Cancer Biol., 4: 219-229, 1993.
8. Nguyen, M., Strubel, N. A., and Bischoff, J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature (Lond.), 365: 267-269, 1993.
9. Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature (Lond.), 376: 517-519, 1995.
10. Tozeren, A., Kleinman, H. K., Grant, D. S., Morales, D., Mercurio, A. M., and Byers, S. W. E-selectin-mediated dynamic interactions of breast and colon cancer cells with endothelial cell monolayers. Int. J. Cancer, 60: 426-431, 1995.
11. Pigott, R., Dillon, L. P., Hemingway, I. H., and Gearing, A. J. H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated cultured endothelial cells. Biochem. Biophys. Res. Commun., 2: 584-589, 1992.
12. Contesso, G., Mouriesse, H., Friedman, S., Genin, J., Sarrazin, D., and Rouesse, J. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1010 patients uniformly treated at Institut Gustave Roussy. J. Clin. Oncol., 5: 1378-1386, 1987.
13. Bonneterre, J., Peyrat, J-P., Beuscart, R., and Demaille, A. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res., 50: 6931-6935, 1990.
14. Koenders, T., and Thorpe, S. M. On behalf of the EORTC receptor study group. Standardization of steroid receptor assays in human breast cancer. IV: Long-term within and between laboratory variation of estrogen and progesterone receptor assays. Eur. J. Cancer Clin. Oncol., 22: 953-954, 1986.
15. Cox, D. R. Regression models and lifetables. J. R. Stat. Soc., 34: 187-200, 1972.
16. Clark, G. M., Dressler, L. G., Owens, M. O., Pounds, G., Oldaker, T., and McGuire, W. L. Prediction of relapse and survival in patients with node-negative breast cancer by DNA flow cytometry. N. Engl. J. Med., 320: 627-633, 1989.
17. O'Reilly, S. M., and Richards, M. A. Is DNA flow cytometry a useful investigation in breast cancer? Eur. J. Cancer, 28: 504-507, 1992.
18. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
19. Van Hoef, M. E. H. M., Knox, W. F., Dhesi, S. S., Howell, A., and Schor, A. M. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer, 29A: 1141-1145, 1993.
20. Martin, L., Green, B., Renshaw, C., Lowe, D., Rudland, P., Leinster, S., and Winstanley, J. Examining the technique of angiogenesis assessment in invasive breast cancer. Br. J. Cancer, 76: 1046-1054, 1997.
21. Peyrat, J-P., Vanlemmens, L., Fournier, J., Huet, G., Révillion, F., and Bonneterre, J. Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancer. Clin. Cancer Res., 4: 189-196, 1998.
22. Peyrat, J-P., Bonneterre, J., Lubin, R., Vanlemmens, L., Fournier, J., and Soussi, T. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet, 345: 621-622, 1995.
23. Pichon, M. F., Pallud, C., Hacene, K., and Milgrom, E. Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer. Eur. J. Cancer, 28A: 1676-1680, 1992.
24. Gerritsen, M. E., Shen, C. P., Atkinson, W. J., Padgett, R. C., Gimbrone, M. A., Jr., and Milstone, D. S. Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro. Lab. Invest., 75: 175-184, 1996.
25. Luo, J., Lin, J., Paranya, G., and Bischoff, J. Angiostatin upregulates E-selectin in proliferating endothelial cells. Biochem. Biophys. Res. Commun., 245: 906-911, 1998.
26. Budson, A. E., Ko, L., Brasel, C., and Bischoff, J. The angiogenesis inhibitor AGM-1470 selectively increases E-selectin. Biochem. Biophys. Res. Commun., 225: 141-145, 1996.
27. Griffioen, A. W., Damen, C. A., Blijham, G. H., and Groenewegen, G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood, 88: 667-673, 1996.
28. Hebbar, M., Révillion, F., Louchez, M. M., Vilain, M. O., Fournier, C., Bonneterre, J., and Peyrat, J-P. The relationship between concentrations of soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin. Cancer Res., 4: 373-380, 1998.
29. Recchi, M. A., Hebbar, M, Hornez, L., Harduin-Lepers, A., Peyrat, J-P., and Delannoy, P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res., 58: 4066-4070, 1998.
30. Hamada, J., Cavanaugh, P. G., and Lotan, O. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br. J. Cancer, 66: 349-354, 1992.
31. Nicosia, R. F., Tchao, R., and Leighton, J. Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin. Exp. Metastasis, 4: 91-104, 1986.
32. Spriggs, D., Imamura, K., Rodriguez, C., Horiguchi, J., and Kufe, D. W. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl. Acad. Sci. USA, 84: 6563-6566, 1987.
33. Hart, I. R., Birch, M., and Marshall, J. F. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev., 10: 115-128, 1991.
34. Nguyen, M., Corless, C. L., Kraling, B. M., Tran, C., Atha, T., Bischoff, J., and Barsky, S. H. Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1α. Am. J. Pathol., 150: 1307-1314, 1997.